GMP Industry News and Developments
Published on: 12/11/2025
New Blog Post Description
GMP

The QMS gap assessment and integration conducted by QSN demonstrates a comprehensive approach to achieving regulatory compliance in the therapeutic goods sector.

GMP certification milestones and global inspection activity are more than regulatory formalities; they represent critical mechanisms for ensuring product quality, patient safety, and corporate credibility.

The proposed temporary GMP exemption by the TGA for personalised bacteriophage therapy manufacture in Australia marks a significant regulatory development for the emerging phage‑therapy sector.